scholarly article | Q13442814 |
P2093 | author name string | Christian Stockmann | |
Ewelina Krzywinska | |||
P2860 | cites work | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis | Q22009936 |
HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing | Q24291102 | ||
Multiple nuclear factors interact with the immunoglobulin enhancer sequences | Q24296245 | ||
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension | Q24307473 | ||
Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1 | Q24320257 | ||
Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1 | Q24336199 | ||
IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses | Q24630608 | ||
Regulation of hypoxia-inducible factor-1alpha by NF-kappaB | Q24657260 | ||
Antimicrobial Activity of Mast Cells: Role and Relevance of Extracellular DNA Traps | Q26739741 | ||
Immunometabolism governs dendritic cell and macrophage function | Q26773266 | ||
T cell metabolism drives immunity | Q26799575 | ||
Tissue oxygen tension monitoring of organ perfusion: rationale, methodologies, and literature review | Q26801225 | ||
Hypoxia-inducible factors in physiology and medicine | Q27013770 | ||
Fueling immunity: insights into metabolism and lymphocyte function | Q27025284 | ||
Neutrophil trails guide influenza-specific CD8⁺ T cells in the airways | Q27331481 | ||
The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells | Q27860620 | ||
Dendritic cells and the control of immunity | Q27860918 | ||
Neutrophil extracellular traps kill bacteria | Q27860996 | ||
The Dual Role of Neutrophils in Inflammatory Bowel Diseases | Q28080144 | ||
Hypoxia-inducible factors regulate T cell metabolism and function | Q28081650 | ||
The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages | Q28143066 | ||
The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes | Q28184994 | ||
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity | Q28299539 | ||
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase | Q28302589 | ||
Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes | Q28504459 | ||
Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1alpha -deficient chimeric mice | Q28584939 | ||
HIF-1alpha is essential for myeloid cell-mediated inflammation | Q29617581 | ||
Oxygen sensing by HIF hydroxylases | Q29617806 | ||
The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting | Q29618424 | ||
Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation | Q29619687 | ||
Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells | Q29619771 | ||
Regulatory T cells: mechanisms of differentiation and function | Q29620731 | ||
Progress on hypoxia-inducible factor-3: Its structure, gene regulation and biological function (Review). | Q30374338 | ||
The role of macrophage polarization in infectious and inflammatory diseases | Q30413135 | ||
Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia | Q30554443 | ||
Hypoxia induced impairment of NK cell cytotoxicity against multiple myeloma can be overcome by IL-2 activation of the NK cells. | Q31118586 | ||
Succinate is an inflammatory signal that induces IL-1β through HIF-1α. | Q33652731 | ||
Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis | Q33685179 | ||
IgE, mast cells, basophils, and eosinophils | Q33760398 | ||
Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia | Q33798508 | ||
Evolutionary conserved regulation of HIF-1β by NF-κB. | Q33813506 | ||
Oxygen sensing strategies in mammals and bacteria. | Q33897916 | ||
The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells | Q33948895 | ||
Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. | Q34001546 | ||
Hypoxia modulates human eosinophil function | Q34023169 | ||
Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation | Q34028645 | ||
Metabolic reprograming in macrophage polarization. | Q34117016 | ||
Why does ARNT2 behave differently from ARNT? | Q34122467 | ||
A membrane protease regulates energy production in macrophages by activating hypoxia-inducible factor-1 via a non-proteolytic mechanism | Q34144698 | ||
Plasmacytoid dendritic cells: recent progress and open questions | Q34162925 | ||
Th17/Treg imbalance induced by increased incidence of atherosclerosis in patients with systemic lupus erythematosus (SLE). | Q50864077 | ||
Eosinophils: biological properties and role in health and disease. | Q51960619 | ||
Need (more than) two to Tango: Multiple tools to adapt to changes in oxygen availability. | Q52372277 | ||
Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types? | Q52668399 | ||
Hypoxia affects dendritic cell survival: role of the hypoxia-inducible factor-1α and lipopolysaccharide. | Q53257878 | ||
Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. | Q54453217 | ||
Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. | Q54709609 | ||
Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB. | Q54858561 | ||
Antigen presentation by dendritic cells in vivo | Q58757885 | ||
The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis | Q83163543 | ||
HIF-1 in T cells ameliorated dextran sodium sulfate-induced murine colitis | Q83763046 | ||
Disturbed Th17/Treg balance in patients with rheumatoid arthritis | Q84644585 | ||
Hypoxia-inducible factor 1 in dendritic cells is crucial for the activation of protective regulatory T cells in murine colitis | Q85666783 | ||
Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. | Q36858877 | ||
Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis | Q36862166 | ||
Hypoxia-inducible factor 1 (HIF-1) pathway | Q36966537 | ||
TLR-independent neutrophil-derived IFN-γ is important for host resistance to intracellular pathogens | Q36967641 | ||
Hypoxia inducible factor (HIF) function in innate immunity and infection | Q37009862 | ||
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. | Q37200886 | ||
Hypoxia-inducible factor 2α regulates key neutrophil functions in humans, mice, and zebrafish. | Q37489023 | ||
S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate. | Q37491480 | ||
Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system | Q37510481 | ||
Interdependence of hypoxic and innate immune responses | Q37586121 | ||
Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation | Q37633213 | ||
Gsk3 is a metabolic checkpoint regulator in B cells | Q37643807 | ||
Regulation of plasmacytoid dendritic cell development. | Q37690000 | ||
Impact of Metabolism on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment | Q37694431 | ||
Basophils: new players in the cytokine network | Q37788426 | ||
Basophils in allergic immune responses | Q37950600 | ||
Neutrophil function: from mechanisms to disease | Q37973773 | ||
Immune regulatory function of B cells. | Q37973774 | ||
Lymph node homing of T cells and dendritic cells via afferent lymphatics | Q37998206 | ||
Cross-presentation by dendritic cells | Q38025870 | ||
Role of hypoxia inducible factor-1α for interferon synthesis in mouse dendritic cells | Q38077750 | ||
The integration of T cell migration, differentiation and function | Q38100061 | ||
Tumor-associated macrophages: functional diversity, clinical significance, and open questions | Q38105286 | ||
TH2, allergy and group 2 innate lymphoid cells | Q38107790 | ||
Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology | Q38128383 | ||
Functional extracellular eosinophil granules: a bomb caught in a trap | Q38153632 | ||
Mast cell progenitors: origin, development and migration to tissues | Q38193606 | ||
Development and function of dendritic cell subsets | Q38212449 | ||
The biology of innate lymphoid cells | Q38319907 | ||
Hypoxia-inducible factor regulates survival of antigen receptor-driven T cells | Q38347067 | ||
Glucose, glycolysis and lymphocyte responses | Q38563943 | ||
Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases | Q38584529 | ||
Heterogeneity and diversity of group 3 innate lymphoid cells: new cells on the block | Q38606216 | ||
miR-210 and hypoxic microvesicles: Two critical components of hypoxia involved in the regulation of killer cells function. | Q38622260 | ||
Immunometabolism: Cellular Metabolism Turns Immune Regulator | Q38624726 | ||
Mast cells in asthma--state of the art. | Q38633155 | ||
Innate lymphoid cells: major players in inflammatory diseases | Q38643190 | ||
Similarities in the Metabolic Reprogramming of Immune System and Endothelium | Q38645730 | ||
Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells | Q38714538 | ||
Hypoxia impairs anti-viral activity of natural killer (NK) cells but has little effect on anti-fibrotic NK cell functions in hepatitis C virus infection | Q38841745 | ||
A guide to immunometabolism for immunologists. | Q38891307 | ||
Hypoxia Enhances Immunosuppression by Inhibiting CD4+ Effector T Cell Function and Promoting Treg Activity | Q38917327 | ||
Hypoxia-inducible factors: key regulators of myeloid cells during inflammation | Q38947313 | ||
HIF-1α-mediated upregulation of TASK-2 K⁺ channels augments Ca²⁺ signaling in mouse B cells under hypoxia | Q38948917 | ||
The hypoxia-inducible factor (HIF) couples immunity with metabolism | Q38975324 | ||
HIF-mediated innate immune responses: cell signaling and therapeutic implications | Q38989126 | ||
Formation of Neutrophil Extracellular Traps under Low Oxygen Level. | Q39117515 | ||
Constitutive Glycolytic Metabolism Supports CD8(+) T Cell Effector Memory Differentiation during Viral Infection. | Q39194568 | ||
MYC and HIF in shaping immune response and immune metabolism | Q39211916 | ||
What Fuels Natural Killers? Metabolism and NK Cell Responses | Q39249602 | ||
Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. | Q39321728 | ||
Oxygen Metabolism and Innate Immune Responses in the Gut. | Q39433728 | ||
von Hippel-Lindau protein adjusts oxygen sensing of the FIH asparaginyl hydroxylase | Q39593358 | ||
Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia | Q39698671 | ||
Nitric oxide causes macrophage migration via the HIF-1-stimulated small GTPases Cdc42 and Rac1. | Q39838660 | ||
Innate lymphoid cells at the interface between obesity and asthma. | Q40062668 | ||
TGF-β-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance. | Q40412394 | ||
Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-β and miR23a transfer | Q40437768 | ||
Hypoxia inhibits the expression of the CCR5 chemokine receptor in macrophages | Q40544126 | ||
Short Term Hypoxia Synergizes with Interleukin 15 Priming in Driving Glycolytic Gene Transcription and Supports Human Natural Killer Cell Activities | Q40693797 | ||
Cutting Edge: Hypoxia-Inducible Factor 1 Negatively Regulates Th1 Function | Q40731073 | ||
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway | Q40788629 | ||
Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension | Q41052822 | ||
Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity | Q41486353 | ||
Neutrophils as Components of Mucosal Homeostasis. | Q41597529 | ||
HIF1α and metabolic reprogramming in inflammation. | Q41678886 | ||
The immune diet: meeting the metabolic demands of lymphocyte activation | Q41898658 | ||
PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells | Q42419970 | ||
HIF-1alpha expression regulates the bactericidal capacity of phagocytes | Q42876119 | ||
Involvement of hypoxia-inducible factor-1 HiF(1alpha) in IgE-mediated primary human basophil responses | Q43273725 | ||
Germinal Center Hypoxia Potentiates Immunoglobulin Class Switch Recombination | Q43286092 | ||
Mast cells can mediate vascular permeability through regulation of the PI3K-HIF-1alpha-VEGF axis | Q43685111 | ||
Expression of proinflammatory cytokines via HIF-1alpha and NF-kappaB activation on desferrioxamine-stimulated HMC-1 cells | Q43763430 | ||
Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha | Q44606435 | ||
Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function | Q44869825 | ||
Life with oxygen | Q45345070 | ||
Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis | Q45737030 | ||
All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. | Q45991876 | ||
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression. | Q46017879 | ||
Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense | Q46197286 | ||
Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity. | Q46373208 | ||
Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis | Q46377120 | ||
Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages | Q46485595 | ||
Dendritic cell reprogramming by the hypoxic environment | Q47249620 | ||
Regulation of immunity and inflammation by hypoxia in immunological niches | Q47708732 | ||
Influence of hypoxia-inducible factor 1α on dendritic cell differentiation and migration | Q47844444 | ||
Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms. | Q48025116 | ||
Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells | Q48239332 | ||
Hypoxia-inducible factor-1α is a critical transcription factor for IL-10-producing B cells in autoimmune disease | Q49212691 | ||
Metabolic Regulation of Innate Lymphoid Cell-Mediated Tissue Protection-Linking the Nutritional State to Barrier Immunity. | Q49630984 | ||
E3 Ligase VHL Promotes Group 2 Innate Lymphoid Cell Maturation and Function via Glycolysis Inhibition and Induction of Interleukin-33 Receptor. | Q49917932 | ||
Mast cells, basophils and eosinophils: From allergy to cancer | Q50081347 | ||
Involvement of hypoxia-inducible factor-1 in the inflammatory responses of human LAD2 mast cells and basophils | Q34217833 | ||
B-cell biology and development | Q34331269 | ||
mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function. | Q34364808 | ||
Succinate: a metabolic signal in inflammation | Q34393631 | ||
Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2. | Q34393801 | ||
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases | Q34658996 | ||
Hypoxia-Inducible Factor (HIF) as a Pharmacological Target for Prevention and Treatment of Infectious Diseases | Q34726144 | ||
Activation-specific metabolic requirements for NK Cell IFN-γ production | Q35071267 | ||
HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells | Q35102340 | ||
HIF transcription factors, inflammation, and immunity | Q35137138 | ||
Antigen-specific transforming growth factor β-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17/Treg cell balance from Th17 predominance to Treg cell predominance. | Q35190507 | ||
Autophagic degradation of GZMB/granzyme B: a new mechanism of hypoxic tumor cell escape from natural killer cell-mediated lysis | Q35319841 | ||
Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. | Q35404457 | ||
The role of the macrophage in sentinel responses in intestinal immunity | Q35545583 | ||
Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27. | Q35592657 | ||
miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis. | Q35621616 | ||
IRF-5-Mediated Inflammation Limits CD8+ T Cell Expansion by Inducing HIF-1α and Impairing Dendritic Cell Functions during Leishmania Infection | Q35653927 | ||
Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand | Q35690181 | ||
Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α. | Q35765467 | ||
Neutrophils prime a long-lived effector macrophage phenotype that mediates accelerated helminth expulsion | Q35776328 | ||
Characterization of Th17 and FoxP3(+) Treg Cells in Paediatric Psoriasis Patients | Q35871966 | ||
The role of HIF-1alpha in myeloid cell inflammation | Q36175335 | ||
The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases | Q36249305 | ||
Integration of oxygen signaling at the consensus HRE. | Q36290265 | ||
Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa | Q36339991 | ||
Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme | Q36349700 | ||
Regulation of the chemokine receptor CXCR4 by hypoxia | Q36371842 | ||
Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity | Q36402484 | ||
B Cells, Antibodies, and More | Q36432935 | ||
Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression | Q36672331 | ||
IL-10-producing regulatory B cells (B10 cells) in autoimmune disease | Q36760499 | ||
Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? | Q36811733 | ||
Myeloid cell HIF-1α regulates asthma airway resistance and eosinophil function | Q36823821 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P577 | publication date | 2018-05-15 | |
P1433 | published in | Biomedicines | Q50816265 |
P1476 | title | Hypoxia, Metabolism and Immune Cell Function. | |
P478 | volume | 6 |
Q91961385 | Activation of Hypoxia-Inducible Factor Signaling Modulates the RNA Protein Interactome in Caenorhabditis elegans |
Q60934959 | Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivo |
Q92857802 | Have Cells Harboring the HIV Reservoir Been Immunoedited? |
Q99590940 | Host Immune Defense upon Fungal Infections with Mucorales: Pathogen-Immune Cell Interactions as Drivers of Inflammatory Responses |
Q64086450 | Hypoxia and the regulation of myeloid cell metabolic imprinting: consequences for the inflammatory response |
Q94445694 | Investigating the epithelial barrier and immune signatures in the pathogenesis of equine insect bite hypersensitivity |
Q92538708 | Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack |
Q64110626 | Molecular Aspects of Dendritic Cell Activation in Leishmaniasis: An Immunobiological View |
Q64093549 | Morphological Characteristics of the Thymus and Spleen and the Subpopulation Composition of Lymphocytes in Peripheral Blood during Systemic Inflammatory Response in Male Rats with Different Resistance to Hypoxia |
Q57464859 | Obesity and gastrointestinal cancer: the interrelationship of adipose and tumour microenvironments |
Q93147363 | Recent Findings in the Regulation of Programmed Death Ligand 1 Expression |
Q92238807 | Regulation of Adaptive Immune Cells by Sirtuins |
Q90088301 | The CRISPR-Cas9 crADSL HeLa transcriptome: A first step in establishing a model for ADSL deficiency and SAICAR accumulation |
Q92136364 | Wnt Antagonists in Hematopoietic and Immune Cell Fate: Implications for Osteoporosis Therapies |
Search more.